International Project Launched to Sequence Human Microbiome, Share Data


By Catherine Varmazis

Oct. 16, 2008 | In Heidelberg, Germany, today researchers from eight countries and the European Commission announced the formation of a new research enterprise, the International Human Microbiome Consortium (IHMC), which will sequence the genomes of tens of thousands of microorganisms that live in and on the human body and that influence human health.

Initial funding of more than US$200 million is being provided by the U.S. National Human Genome Research Institute (NHGRI) and the European Commission (EC).

Jane Peterson, associate director of extramural research at the NHGRI, said international collaboration is very important in advancing science, and that “the sum is more than the parts.” Participants in the IHMC have agreed in principle to the free and open release of data and resources, and the coordination of research plans, as well as to sharing innovative developments, she reported. Data from microbiome research already being conducted by the NIH Human Microbiome Project and the EC Metagenomics of the Human Intestinal Tract (MetaHIT) project will contribute an initial set of microbial genomes to the IHMC. Because the field is so young – less than three years old – there is much to be gained by collaboration, Peterson said.

Christian Desaintes, from the Research Directorate of the European Commission, said the IHMC’s goal for five years hence is to be sequencing 1000 microbiome genomes from over 1000 individuals’ body parts. The parts in question are the skin, mouth, nasal passages, gastro-intestinal tract, and urogenital tract.

Dusko Ehrlich, coordinator of the MetaHIT project, encapsulated the vast scale of the work to be done: “We know there are 10 times more microbial cells in our bodies than our own cells. We know there are 100 times more microbial genes that are active in our bodies than our own genes. We know that microbes that live within us play an important role in our health and disease. But we do not know by far what these microorganisms are and how they act. The IHMC aims to provide a description of microbial genes and genomes and find how they work.”

The MetaHIT project will contribute to a reference catalog of genes and genomes by analyzing the microbiomes of hundreds of individuals from the Mediterranean region (Spain) and Nordic region (Denmark), initially focusing on two conditions of increasing concern: obesity and inflammatory bowel disease.

Responding to a reporter’s question, the speakers acknowledged that developing countries were conspicuously absent from this project, and that environmental differences are crucial to a full understanding of human disease. They expressed the hope that interest in the IHMC project would spur additional funding from private sources, to enable less wealthy countries to participate.

One example of the possible relationship between environment and microbiomes was proffered by a researcher from China. He said it is not clear why Chinese who adopt a Western diet tend to develop metabolic diseases of the West that do not affect those who eat only a traditional Chinese diet. He speculated that it might be related to the microbiomes in the gut. By studying the microbiomes of Chinese who eat only a traditional diet, the IHMC project could shed light on this problem.

For more details on today’s announcement, see the press release.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

10 Secrets to Recession-Proof Your Business
Sponsored by Coupa


Read this white paper to discover 10 strategies smart companies deploy to recession-proof their business.
Leaders generally face hard choices on how to mange a company during an economic downturn and
behave in one of three ways:
1) “The ostrich” - Preserve the status quo/hope for the best
2) “The bull in the china shop” - Blindly cut expenses across the board
3) “The fox” - Use the downturn to make your business more effective and position it for future growth

Learn how to behave “like a fox” and use a recession as a means to pounce on emerging trends.



High-Performance Computing in Life Science & Education
Sponsored by SGI and Intel
The varied collection of Bio-IT World articles and insights assembled in this BriefingON examine key trends in HPC infrastructure and how researchers are putting their best computational resources to use. Provided here are stories and lessons around the effective use of high performance computing in life science. Download the BriefingON.


Software Helps Doping Control Lab Streamline Results Management
Sponsored by Waters
The Karolinska University Hospital’s Doping Control Lab tests thousands of samples annually for stimulants, diuretics, and other masking agents. Increased regulatory pressure and new technologies increased the number of samples analyzed creating data management challenges. Waters® NuGenesis® Scientific Data Management System and TargetLynx™ Application Manager software were used to reduce the time required to calculate, review and search results.


Life Science Webcasts & Podcasts

Medidata Solutions

Rising Clinical Trial Delays and Costs - Addressing the Cause, Not the Symptoms

Protocol complexity is taking a toll on clinical study speed and efficiency: increasingly complicated and ambitious protocols are not only burdening sites and study volunteers but are also prolonging trials and increasing expenses. In response, sponsors have turned to global study placement, restructured site relationships and new site management practices, but the problem remains.

This podcast will discuss:

  • Why these responses address only the symptoms, not the underlying cause, of rising clinical trial delays and costs.
  • Results of a recent joint Tufts University / Medidata Solutions study.
  • New metrics benchmarking protocol design trends.
  • Systematic protocol design improvements and why they are essential to clinical trial performance excellence.

Speakers: Ken Getz, Senior Research Fellow at the Tufts Center for the Study of Drug Development, and Ed Seguine, General Manager, Trial Planning Solutions at Medidata.

Download Now



More Podcasts

Job Openings

Sequencing Instrument Software Team Leader – Oxford Nanopore Technologies, UK
We are seeking a highly motivated and dynamic individual to join our rapidly growing informatics team, to lead the development of the software and computing subsystem of our revolutionary DNA sequencing system. The candidate will be required to work to aggressive timelines within an agile development process. Visit www.nanoporetech.com/vacancies

Related Resources & Products

Next-Generation Sequencing: Scientific and Commercial Implications of the $1000 Genome
Next-Generation Sequencing: Scientific and Commercial Implications of the $1000 Genome
Electronic Data in Clinical Trials
Electronic Data in Clinical Trials
BioTeam Next-Generation Sequencing Data Management DVD
BioTeam Next-Generation Sequencing Data Management DVD




For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to [email protected].